---
layout: splash
title: 한미약품 (128940)
excerpt: 한미약품의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
keywords: 한미약품, 128940
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 319,500 | <span style="color: tomato">0.9<small>%</small></span> | P:의약품 | 27.7 | 4.2 | 0.2<small>%</small> |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 의약품 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 의약품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 2010년 7월 30일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 박재현 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [nan](nan){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 04&#x2011;30 | | [연결재무제표기준영업(잠정)실적(공정공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240430800427){:target="_blank"} |
| 04&#x2011;25 | | [기업설명회(IR)개최(안내공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240425800533){:target="_blank"} |
|  | | [결산실적공시예고(안내공시)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240425800511){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![128940](/stock/images/128940.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 319,500 | <span style="color: tomato">0.9<small>%</small></span> | <span style="color: tomato">1.4<small>%</small></span> | <span style="color: cornflowerblue">-0.3<small>%</small></span> | <span style="color: tomato">1.3<small>%</small></span> | <span style="color: tomato">8.5<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">2.1<small>%</small></span> | 37.7<small>%</small> | 0.06 | -19.1<small>%</small> | -9.1<small>%</small> | -0.1 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 27.7 | 4.2 | 0.2<small>%</small> | - |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/128940/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=128940){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A128940&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=128940){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/128940){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/128940/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![128940](/stock/images/128940_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 2.1<small>%</small> | 37.7<small>%</small> | 0.06 | -19.1<small>%</small> | -9.1<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 4.5<small>%</small> | 37.2<small>%</small> | 0.12 | -21.3<small>%</small> | -9.2<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -4.2<small>%</small> | 25.0<small>%</small> | -0.17 | -32.0<small>%</small> | -15.4<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | -12.4<small>%</small> | 21.9<small>%</small> | -0.57 | -24.1<small>%</small> | -13.7<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | -16.5<small>%</small> | 27.5<small>%</small> | -0.60 | -27.0<small>%</small> | -13.8<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | -30.2<small>%</small> | 24.8<small>%</small> | -1.22 | -32.5<small>%</small> | -19.7<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | -32.4<small>%</small> | 27.4<small>%</small> | -1.18 | -37.9<small>%</small> | -24.7<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | -16.1<small>%</small> | 34.9<small>%</small> | -0.46 | -23.6<small>%</small> | -13.6<small>%</small> |
| MACD[^fn_tech_metric_macd] | -2.8<small>%</small> | 27.9<small>%</small> | -0.10 | -24.0<small>%</small> | -11.5<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![128940](/stock/images/128940_corr.png){: .align-center}

|       | [한미사이언스](/008930/) | [셀트리온](/068270/) | [CJ대한통운](/000120/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [리가켐바이오](/141080/) | [대웅](/003090/) | [한진칼](/180640/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![128940](/stock/images/128940_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}